Cisplatin administration following carboplatin desensitization failure in primary peritoneal cancer: a brief report
- Daniel P. GreeneAffiliated withUniversity of Virginia School of Medicine
- , James Stuart FerrissAffiliated withThornton Gynecologic Oncology Service, Department of Obstetrics and Gynecology, University of Virginia Health System Email author
- , Amir A. JazaeriAffiliated withThornton Gynecologic Oncology Service, Department of Obstetrics and Gynecology, University of Virginia Health System
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Platinum-based therapy is the cornerstone of ovarian cancer treatment. Development of platinum hypersensitivity can limit therapeutic options. In this brief report, we present case of successful cisplatin administration following two unsuccessful carboplatin desensitization attempts, and without the need for pre-treatment steroids.
Retrospective chart review was performed.
One case of recurrent primary peritoneal carcinoma previously treated with a carboplatin-based regimen, developed a platinum hypersensitivity. Two attempts at carboplatin desensitization were unsuccessful. Cisplatin was substituted and the patient achieved a complete response to therapy without further hypersensitivity.
Platinum-based therapies are vital to the treatment of primary peritoneal and ovarian carcinoma. Protocols that successfully incorporate platinum agents, despite a platinum hypersensitivity, are clinically relevant.
KeywordsPlatinum hypersensitivity Peritoneal carcinoma Platinum desensitization failure Cisplatin
- Cisplatin administration following carboplatin desensitization failure in primary peritoneal cancer: a brief report
Cancer Chemotherapy and Pharmacology
Volume 66, Issue 2 , pp 265-267
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Platinum hypersensitivity
- Peritoneal carcinoma
- Platinum desensitization failure
- Industry Sectors
- Author Affiliations
- 1. University of Virginia School of Medicine, Charlottesville, VA, USA
- 2. Thornton Gynecologic Oncology Service, Department of Obstetrics and Gynecology, University of Virginia Health System, P.O. Box 800712, Charlottesville, VA, 22908, USA